Howard Capital Management’s ResMed RMD Stock Holding History

Howard Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-935	Closed	-$225K	–	402
2025 Q4	$225K	Buy	935 +4	+0.4%	+$1.02K	﹤0.01%	409
2025 Q3	$255K	Buy	931 +24	+3%	+$6.56K	﹤0.01%	385
2025 Q2	$234K	Buy	+907	New	+$216K	﹤0.01%	379
2025 Q1	–	Sell	-900	Closed	-$206K	–	404
2024 Q4	$206K	Buy	900 +45	+5%	+$10.8K	﹤0.01%	404
2024 Q3	$209K	Buy	+855	New	+$191K	﹤0.01%	381

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Howard Capital Management's RMD Position: Q1 2026 in Review

Howard Capital Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 935 shares — an estimated $225K sold.

Howard Capital Management first reported a position in RMD in Q3 2024 and held it in 5 quarters. The position peaked at $255K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Howard Capital Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Howard Capital Management sold 935 ResMed shares in Q1 2026, an estimated $225K.
Howard Capital Management first reported a position in ResMed in Q3 2024 and held it in 5 quarters.
Howard Capital Management's ResMed position peaked at $255K in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Howard Capital Management's 13F filing for Q1 2026, filed 5 May 2026.